中国药企掀起“BD预告潮”,资本市场买单吗?

医药经济报
23 Jun

6月13日,石药集团宣布与阿斯利康达成战略研发合作协议。根据协议,双方将基于石药集团自主研发的AI驱动药物发现平台,共同开发新型口服小分子候选药物。该AI平台通过分析靶向蛋白与现有化合物的结合模式,利用AI算法进行分子优化,可高效筛选出具有良好开发前景的小分子药物。根据协议约定,石药集团将为阿斯利康选定的多个靶点开发临床前候选药物(PCC),其中包括一款用于免疫疾病治疗的口服小分子疗法。在商业化...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10